Leidos Holdings, Inc.
Time frame: 1 April 2023 - 31 March 2024Article ‘Count’ and ‘Share’ for Leidos Holdings, Inc. based on listed parameters only.
The articles listed below published by authors from Leidos Holdings, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.11 |
Cancer Cell |
4 | 0.08 |
Cancer Research |
2 | 0.19 |
Cell |
2 | 0.10 |
Developmental Cell |
1 | 0.12 |
Genes & Development |
1 | 0.06 |
Immunity |
3 | 0.13 |
Journal of Biological Chemistry |
4 | 0.52 |
Journal of Clinical Investigation |
3 | 0.26 |
Journal of Neuroscience |
1 | 0.03 |
Molecular Cell |
1 | 0.23 |
Nature |
3 | 0.12 |
Nature Communications |
23 | 1.21 |
Nature Immunology |
2 | 0.14 |
Nature Structural & Molecular Biology |
1 | 0.09 |
PLOS Genetics |
1 | 0.20 |
Proceedings of the National Academy of Sciences of the United States of America |
6 | 0.42 |
Science |
1 | 0.14 |
Science Advances |
2 | 0.38 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.